p64 MW | p48 MW

FLOW MODULATION DEVICE

p64 MW | p48 MW

FLOW MODULATION DEVICE

Key features

- Available with coating technology proven to reduce thrombogenicity¹ and SAFE for use with SAPT²
- Independently movable wire for stability and controlled positioning
- Platinum filled DFT wires provide full visibility
- Friction-locking principle for easy detachment
- Designed for the treatment of vessels from 1.75 to 5 mm

1 Lenz-Habijan, T., Bhogal, P., Peters, M., Bufe, A., Moreno, R.M., Bannewitz, C., Monstadt, H.D., & Henkes, H. (2018). Hydrophilic Stent Coating Inhibits Platelet Adhesion on Stent Surfaces: Initial Results In Vitro. Cardiovascular and Interventional Radiology, 41, 1779 - 1785.

2 Pierot, L. (2025, June 2). New Frontiers in Intracranial Aneurysm Treatment: The COATING Randomised Trial: Interim analysis of the primary endpoint and safety data up to 30 day FU. LINNC Paris 2025, Paris. France

Key features

- Available with coating technology proven to reduce thrombogenicity¹ and SAFE for use with SAPT²
- Independently movable wire for stability and controlled positioning
- Platinum filled DFT wires provide full visibility
- Friction-locking principle for easy detachment
- Designed for the treatment of vessels from 1.75 to 5 mm

1 Lenz-Habijan, T., Bhogal, P., Peters, M., Bufe, A., Moreno, R.M., Bannewitz, C., Monstadt, H.D., & Henkes, H. (2018). Hydrophilic Stent Coating Inhibits Platelet Adhesion on Stent Surfaces: Initial Results In Vitro. Cardiovascular and Interventional Radiology, 41, 1779 - 1785.

2 Pierot, L. (2025, June 2). New Frontiers in Intracranial Aneurysm Treatment: The COATING Randomised Trial: Interim analysis of the primary endpoint and safety data up to 30 day FU. LINNC Paris 2025, Paris. France

Story of Valeria - Brain Aneurysm Survivor

Flow Diverter - Movable Wire

See the p64 MW | p48 MW in action:

Please ACCEPT MARKETING COOKIES to watch this video.

See the p64 MW | p48 MW in action:

Please ACCEPT MARKETING COOKIES to watch this video.

Download the p64 MW | p48 MW Product Brochure here.

Prior to use, refer to the “Instructions for Use” for complete and specific indications, contraindications, all warnings, precautions and potential adverse events.
The p64 MW | p48 MW Flow Modulation Device has received the CE Mark (CE 0297). It is not approved for sale nor is it available for sale or use in the United States.
Products and associated components are not available in all countries or regions. Please contact your phenox representative for details regarding product availability.

SEE OTHER TREATMENT SOLUTIONS